Zalmai Hakimi is the Head of Global Health Economics and Outcomes Research at Sobi - Swedish Orphan Biovitrum AB (publ) since March 2019, previously serving as Director Global HEOR at Square Health Economics B.V from April 2018 to December 2021. Prior experience includes various roles at Astellas Pharma from November 2009 to April 2018, where responsibilities included Director and Associate Director of Global HEOR, and Senior Manager of Global HEOR, as well as Project Leader for Health Economics & Reimbursement at Sanofi from March 2003 to October 2009. Zalmai Hakimi holds a Doctor of Philosophy (PhD) in Health Economics from The Manchester Metropolitan University, and additional qualifications in Market Access, Economics and Management of Health Care Systems, Regulatory Affairs and Analytical Chemistry, and a PharmD, showcasing a strong academic foundation in health economics and related fields.
This person is not in the org chart
This person is not in any teams
This person is not in any offices